Zoledronic Acid (Standard)
Based on 1 Customer Validation
Zoledronic Acid (Standard) is the analytical standard of Zoledronic Acid. This product is intended for research and analytical applications. Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 118072-93-8
- 화학식: C5H10N2O7P2
- 분자량:272.09
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- 순도&문서
-
Help & FAQs
-
HY-13777
Zoledronic AcidAnti-resorptive Agant -
HY-13991
CCG-1423Rho/MRTF/SRF Pathway Inhibitor -
HY-15723A
NSC 23766 trihydrochlorideRac Inhibitor -
HY-13963
ZCL278Cdc42 Inhibitor -
HY-12810
EHop-016Rac1/Rac3 Inhibitor -
HY-15723
NSC 23766Ras Inhibitor -
HY-B0256
AzathioprineAutoimmunity Inhibitor -
HY-18980
RottlerinPKC Inhibitor -
HY-10342
EnzastaurinPKCβ Inhibitor -
HY-16659
EHT 1864Rac Family Inhibitor -
HY-12874
CASINGTPase Cdc42 Inhibitor -
HY-12048
Chelerythrine chlorideBcl-2 Family Inhibitor
Product Information
Information
신청
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 118072-93-8
-
Appearance Solid
-
분자량 272.09
-
화학식 C5H10N2O7P2
-
Color White to off-white
-
SMILES
OC(P(O)(O)=O)(P(O)(O)=O)CN1C=CN=C1
-
Synonyms
Zoledronate (Standard); CGP 42446 (Standard); CGP42446A (Standard); ZOL 446 (Standard)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
[1]. Lianwei Wang, et al. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer. 2020; 20: 1059. [Content Brief]
[2]. Hyung Joon Kim, et al. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis. Int J Mol Sci. 2019 Mar; 20(6): 1467. [Content Brief]
[3]. Xiao-Lin Huang, et al. Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways. Int J Mol Med. 2019 Aug;44(2):582-592. [Content Brief]
[4]. XIN HUANG, et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. 2016 Jan; 13(1): 613-622. [Content Brief]
[5]. Samantha Pozzi, et al. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. 2009 Sep 15;15(18):5829-39. [Content Brief]
[6]. Shea GKH, et al. Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial. J Orthop Res. 2022 Feb 23. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Zoledronic Acid (Standard) Related Classifications
HY-13777R Related Classifications
Powered by Bioz